| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | REGENERON PHARMACEUTICALS | 99,748 | 46,397,000 | 13.54% | ||
| 2 | NOVO-NORDISK A S | 672,721 | 36,488,000 | 10.65% | ||
| 3 | ALEXION PHARMACEUTIC | 166,914 | 26,104,000 | 7.62% | ||
| 4 | SEATTLE GENETICS INC | 636,730 | 24,552,000 | 7.17% | ||
| 5 | RENAISSANCERE HOLDINGS LTD | 216,790 | 23,049,000 | 6.73% | ||
| 6 | BERKSHIRE HATHAWAY INC DEL | 114 | 22,257,000 | 6.50% | ||
| 7 | SANOFI SPOND FUNSPONSORED ADR | 2,357,558 | 20,063,000 | 5.86% | ||
| 8 | Senomyx Inc | 4,206,491 | 18,761,000 | 5.48% | ||
| 9 | ALPHABET INC | 27,738 | 16,876,000 | 4.93% | ||
| 10 | MONSANTO CO NEW | 177,090 | 15,113,000 | 4.41% | ||
| 11 | INTREXON CORP | 417,569 | 13,279,000 | 3.88% | ||
| 12 | DIGIMARC CORP | 384,304 | 11,740,000 | 3.43% | ||
| 13 | CORNING INC | 637,846 | 10,920,000 | 3.19% | ||
| 14 | PTC | 313,701 | 9,957,000 | 2.91% | ||
| 15 | ALLISON TRANSMISSION HLDGS INC COM | 347,083 | 9,264,000 | 2.70% | ||
| 16 | ALPHABET INC | 12,956 | 8,271,000 | 2.41% | ||
| 17 | JOHNSON & JOHNSON | 75,765 | 7,073,000 | 2.06% | ||
| 18 | UBIQUITI NETWORKS | 135,375 | 4,588,000 | 1.34% | ||
| 19 | BERKSHIRE HATHAWAY INC DEL | 35,011 | 4,565,000 | 1.33% | ||
| 20 | VALEANT PHARMACEUTICALS INTL | 24,025 | 4,286,000 | 1.25% | ||
| 21 | ENSTAR GROUP LIMITED COM | 25,294 | 3,794,000 | 1.11% | ||
| 22 | MASTERCARD INCORPORATED | 33,690 | 3,036,000 | 0.89% | ||
| 23 | NIDEC CORP SPONS ADR | 77,428 | 1,342,000 | 0.39% | ||
| 24 | ALLEGHANY CORP | 640 | 300,000 | 0.09% | ||
| 25 | RANDGOLD RES LTD | 4,500 | 266,000 | 0.08% | ||
| 26 | CONOCOPHILLIPS | 1,699 | 81,000 | 0.02% | ||
| 27 | EXXON MOBIL CORP | 715 | 53,000 | 0.02% | ||
| 28 | PFIZER INC | 1,617 | 51,000 | 0.01% | ||
| 29 | ABBVIE INC | 491 | 27,000 | 0.01% | ||
| 30 | ABBOTT LABS | 640 | 26,000 | 0.01% | ||
| 31 | PHILLIPS 66 | 247 | 19,000 | 0.01% | ||
| 32 | GLAXOSMITHKLINE PLC | 239 | 9,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000905718-15-000900, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.